In a recent study, University of Michigan researchers created a cellular atlas of prostate cancer using mouse models to better understand why some tumors resist common therapies. By comparing their results with human data, the team identified pathways that may drive this resistance. Read the full article to learn how this work could help shape new treatment strategies.
